Ibex Medical Analytics Establishes Biopharma Advisory Board to Advance AI-Powered Precision Diagnostics
Ibex Medical Analytics announced the establishment of a new Biopharma Advisory Board on May 5, 2026.
Initial members are Ruth March, PhD, OBE, FMedSci, FRSB (former Senior VP of Precision Medicine and Biosamples at AstraZeneca) and Paolo Tarantino, MD, PhD.
Additional experts expected to join in coming months.
The board provides strategic and scientific guidance for expanding Biopharma Services, supporting biomarker development and companion diagnostics (CDx).
Supports full lifecycle from early development to clinical validation and global deployment.
Builds on partnerships like Ibex Breast HER2 for oncology therapies such as antibody-drug conjugates (ADCs).